Merz Pharmaceuticals, LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$6.3M
Doctors Paid
6,580
Transactions
22,063
2024 Total
$1.1M
Payment Breakdown by Category
Research$3.3M (52.5%)
Consulting$835,620 (13.2%)
Food & Beverage$639,568 (10.1%)
Travel$328,165 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.3M | 385 | 52.5% |
| Consulting Fee | $835,620 | 320 | 13.2% |
| Food and Beverage | $639,568 | 20,306 | 10.1% |
| Grant | $515,292 | 52 | 8.1% |
| Travel and Lodging | $328,165 | 445 | 5.2% |
| Debt forgiveness | $196,465 | 51 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $175,251 | 82 | 2.8% |
| Charitable Contribution | $130,000 | 1 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $125,050 | 39 | 2.0% |
| Honoraria | $32,401 | 34 | 0.5% |
| Education | $24,113 | 348 | 0.4% |
Payments by Type
Research
$3.3M
385 transactions
General
$3.0M
21,678 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Period to Investigate the Efficacy and Safety of NT 201 in the Unilateral and Bilateral Treatment of Essential Tremor of the Upper Limb | $857,215 | 5 | 136 |
| Radiesse Post Approval Study (PAS) for Treatment of Hands with Moderate to Very Severe Dorsal Volume Loss | $808,700 | 0 | 70 |
| Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 in the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury in Adult Subjects, Followed by an Open Label Extension With or Without Combined Upper Limb Treatment | $626,322 | 1 | 84 |
| Evaluation of Pain with Belotero Balance with Integral Lidocaine for Correction of the Nasolabial Folds | $187,625 | 0 | 10 |
| Botulinum Toxin Injections and Tinnitus | $121,023 | 0 | 7 |
| Evaluating the Effects of Calcium Hydroxylapatite (Radiesse) and Hyaluronic Acid (Voluma) on Human Skin Elastin Staining Levels and Nasolabial Fold Wrinkle Score Study after Radiesse Injection | $79,953 | 0 | 3 |
| In Vivo Analysis of the Degradation of Radiesse | $71,250 | 0 | 3 |
| Simulines | $69,475 | 0 | 8 |
| A prospective, randomized, single-center, evaluator-blinded clinical trial evaluating the safety, efficacy, and patient satisfaction of injectable calcium hydroxylapatite (Radiesse Plus, Merz Aesthetics) in combination with micro-focused ultrasound for rejuvenation of the aging chest | $62,775 | 0 | 1 |
| Evaluation of the Ulthera System for Lifting of Breast Tissue | $55,250 | 0 | 2 |
| A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines | $45,187 | 0 | 2 |
| A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Incobotulinum Toxin Type A for the Functional Improvement of Lower Extremity Spasticity in Patients with Multiple Sclerosis (Previously IIT-2011-032) | $35,760 | 0 | 1 |
| Radiesse Post Approval Safety Study Radiological Evaluation of Implantation in the Hands | $32,000 | 0 | 2 |
| A Bilateral Paired Subject blinded comparison and assessment of submalar cheek augmentation between Radiesse Plus and Voluma | $30,069 | 0 | 2 |
| CD Flex | $29,349 | 0 | 12 |
| Radiesse Post Approval Safety Study- Radiological Evaluation of Implantation in the Hands | $27,200 | 0 | 2 |
| ULT-146 Simulines | $25,500 | 0 | 7 |
| Pediatric Lower Limb spasticity split-leg design study EU (ELLIE) | $24,750 | 2 | 2 |
| A Placebo-Controlled, Double-Blind, Randomized, Cross Over Pilot Study Of The Efficacy And Tolerability Of Incobotulinum Toxin A (Xeomin) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand | $23,532 | 0 | 1 |
| Cellfina 5 year follow-up | $22,100 | 0 | 3 |
| A Placebo Controlled, Double-Blind, Randomized, Cross-Over Pilot Study of the Efficacy and Tolerability of Incobotulinum Toxin A (Xeomin) as a Treatment for Focal Task-Specific Dystonia of the Musician's Hand (Previously MERZ IIT 2012-046) | $15,927 | 0 | 1 |
| PNP - Peripheral Neuropathic Pain (PaiNT) | $13,600 | 0 | 1 |
| Upper Extremity injection of Xeomin and Changes in Gait Related Mobility in Adults after Stroke | $11,474 | 0 | 10 |
| Upper Extremity Injection of Xeomin and Changes in Gait Related Mobility in Adults After Stroke | $11,421 | 0 | 1 |
| Xeomin and Isometrics for Adolescent Idiopathic Scoliosis of the Lumbar Spine | $9,435 | 0 | 2 |
| ULT-302 China Pilot | $8,380 | 0 | 4 |
| Buttocks Pilot | $3,900 | 0 | 2 |
| Retrospective Study and Consensus Treatment Protocol of Guided Subcision using the Cellfina Device for the Treatment of Cellulite | $3,750 | 0 | 1 |
| Combination Therapy Approach to Tear Trough Deformities and Under Eye Appearance using Micro-Focused Ultrasound and Cohesive Polydensified Matrix Hyaluronic Acid Filler | $2,950 | 0 | 1 |
| ULT-302 China US Pilot | $2,500 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Gabriel Tatarian, D.o, D.O | Neurology | Philadelphia, PA | $147,599 | $0 |
| Monica Verduzco-Gutierrez, M.d, M.D | Physical Medicine & Rehabilitation | San Antonio, TX | $133,390 | $0 |
| Dr. Gerard Francisco, M.d, M.D | Physical Medicine & Rehabilitation | Houston, TX | $131,412 | $0 |
| Todd Stitik, M.d, M.D | Pain Medicine | Newark, NJ | $113,747 | $0 |
| Fernando Pagan | Neurology | Washington, DC | $106,232 | $0 |
| Dr. Kenneth Martinez, M.d, M.D | Neurology | Aliso Viejo, CA | $79,816 | $0 |
| Dr. Steven Escaldi, D.o, D.O | Specialist | Edison, NJ | $53,841 | $0 |
| Dr. Nicholas Ketchum, M.d, M.D | Physical Medicine & Rehabilitation | Milwaukee, WI | $49,072 | $0 |
| Michael O'dell, Md, MD | Physical Medicine & Rehabilitation | New York, NY | $39,470 | $0 |
| Philip Charles, Md, MD | Neurological Surgery | Nashville, TN | $37,642 | $0 |
| Dr. Jason Aldred, M.d, M.D | Neurology | Spokane, WA | $37,333 | $0 |
| Dr. Heather Walker, M.d, M.D | Spinal Cord Injury Medicine | North Charleston, SC | $35,879 | $0 |
| Peter Mcallister, M.d, M.D | Neurology | Fairfield, CT | $30,717 | $0 |
| Dr. Laxman Bahroo, D.o,, D.O, | Neurology | Washington, DC | $30,105 | $0 |
| Ramsey Falconer, M.d, M.D | Neurology | Alexandria, VA | $29,590 | $0 |
| Robert Owens, M.d, M.D | General Practice | New Orleans, LA | $29,326 | $0 |
| Dr. David Simpson, M.d, M.D | Neurology | New York, NY | $29,079 | $0 |
| Dr. Lester Duplechan, M.d, M.D | Physical Medicine & Rehabilitation | Crestview Hills, KY | $27,577 | $0 |
| Dr. Neil Jasey, M.d, M.D | Physical Medicine & Rehabilitation | New York, NY | $25,569 | $0 |
| Dr. Ryan Hafner, M.d, M.D | Physical Medicine & Rehabilitation | Sarasota, FL | $24,707 | $0 |
| Dr. Stuart Isaacson, Md, MD | Neurology | Boca Raton, FL | $22,598 | $0 |
| Dr. Teshamae Monteith | Neurology | Miami, FL | $21,089 | $0 |
| Yekyung Kong | Physical Medicine & Rehabilitation | West Orange, NJ | $20,535 | $0 |
| Edward Chang, Md, MD | Otolaryngology | Santa Rosa, CA | $18,939 | $0 |
| Dr. Edward Dabrowski, M.d, M.D | Physical Medicine & Rehabilitation | Roseville, MI | $17,140 | $0 |
Ad
Top Products
- Xeomin $4.0M
- INBRIJA $53,687
Payment Categories
- Food & Beverage $639,568
- Consulting $835,620
- Travel & Lodging $328,165
- Research $3.3M
About Merz Pharmaceuticals, LLC
Merz Pharmaceuticals, LLC has made $6.3M in payments to 6,580 healthcare providers, recorded across 22,063 transactions in the CMS Open Payments database. In 2024, the company paid $1.1M. The top product by payment volume is Xeomin ($4.0M).
Payments were distributed across 155 medical specialties. The top specialty by payment amount is Neurology ($868,894 to 1,544 doctors).
Payment categories include: Food & Beverage ($639,568), Consulting ($835,620), Research ($3.3M), Travel & Lodging ($328,165).